Invasive Candidiasis
📧 Sign up to get email alerts when something new happens for Invasive Candidiasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-10Clinical Trial Results: A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole [Phase 3]
A Phase 3 randomized, double-blind study comparing oral ibrexafungerp versus fluconazole following IV echinocandin for invasive candidiasis …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation [Phase 3]
Phase 3 trial evaluating rezafungin versus standard antimicrobial prophylaxis to prevent invasive fungal diseases in adults undergoing allog…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Non-Conventional Microbiological Methods in the Diagnosis of Candidemia [NA]
A completed clinical trial evaluating non-conventional microbiological methods for the diagnosis of candidemia and invasive candidiasis.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole [Phase 3]
Phase 3, randomized, double-blind trial evaluating ibrexafungerp vs fluconazole after IV echinocandin for invasive candidiasis and candidemi…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Pharmacokinetics of Micafungin in Patients of Intensive Care Units [Phase 4]
Phase 4 pharmacokinetic study of micafungin in ICU patients with invasive candidiasis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis [NA]
A completed clinical trial evaluating hepatosplenic candidiasis using PET scans and immune response analysis in patients with invasive candi…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus [Phase 3]
Phase 3 trial of ABCD for Injection for invasive candidiasis and invasive aspergillosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment [Phase 3]
Phase 3 study assessing ibrexafungerp in patients with invasive and mucocutaneous fungal diseases refractory to or intolerant of standard tr…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia [Phase 4]
A Phase 4 trial evaluating micafungin for invasive candidiasis or candidemia was terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects [Phase 2]
Phase 2 trial by Astellas evaluating pre-emptive treatment for invasive candidiasis in high-risk surgical subjects has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug [Phase 1]
Phase 1 study of Mycamine in children to evaluate safety and drug blood levels in fungal infections; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis
A completed Mayo Clinic clinical trial evaluated the role of interferon-gamma in immune responses to invasive candidiasis. The study finding…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES) [Phase 3]
Phase 3 open-label study evaluating oral ibrexafungerp (SCY-078) for invasive candidiasis and candidemia caused by Candida auris was complet…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis [Phase 2]
Phase 2 trial comparing oral ibrexafungerp (SCY-078) to standard-of-care after IV echinocandin in invasive candidiasis; study completed with…
-
CLINICAL_TRIALS trial_result · 2023-05-08Clinical Trial Update: Efficacy of Prophylactic Fluconazole Therapy in Preterm and Very Low Birth Weight Neonates in Preventing Invasive Fungal Infection. [Phase 3]
Phase 3 trial evaluating prophylactic fluconazole to prevent invasive fungal infection in preterm and very low birth weight neonates; study …
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris [Phase 2]
Open-label Phase 2 trial evaluating APX001 (fosmanogepix) for candidemia and invasive candidiasis caused by Candida auris; study completed w…
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis [Phase 3]
Phase 3 trial comparing rezafungin to caspofungin in candidemia and invasive candidiasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: Evaluate Bioequivalence of Micafungin (50mg/Vial) [Phase 4]
Phase 4 trial update evaluating bioequivalence of micafungin 50 mg/vial in invasive candidiasis has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-12Clinical Trial Update: Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin [Phase 4]
A Phase 4 trial comparing two diagnostic tests in patients with suspected invasive candidiasis who are being treated with micafungin; the st…
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension [Phase 2]
Phase 2 trial comparing CD101 to caspofungin followed by oral step-down in candidemia and invasive candidiasis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis [Phase 2]
Phase 2 clinical trial update for Amphotericin B cholesteryl sulfate complex for injection (ABCD) in invasive candidiasis and invasive asper…
-
CLINICAL_TRIALS trial_result · 2018-09-14Clinical Trial Update: Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis [Phase 3]
Phase 3 clinical trial update on anidulafungin for invasive candidiasis in children has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064) [Phase 2]
A Phase 2 trial comparing caspofungin to amphotericin B deoxycholate for invasive candidiasis in neonates and infants was terminated; result…
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: Invasive Candidiasis in Saudi ICUs
Clinical trial update for invasive candidiasis in Saudi ICUs; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections [Phase 3]
Phase 3 trial evaluating isavuconazole (BAL8557) for candidemia and invasive candidiasis; results were posted in 2017.